Delivery Order SPE2DB22D2007-SPE2DB25FJ5BS
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $17,344.30 to AmerisourceBergen Drug Corp for the supply of Andexxa 200 mg vials. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 4, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania location. The contract utilizes no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements. This...
- The Defense Logistics Agency awarded a $6,931.53 delivery order to AmerisourceBergen Drug Corp for 200 mg vials of Andexxa, an antidote used to reverse the anticoagulant effects of certain blood thinners. This firm fixed-price contract, issued on July 2, 2025, with an ultimate completion date of July 24, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $8,672.15 to AmerisourceBergen Drug Corp for Andexxa 200 mg vials, with a completion date of July 1, 2025. This competitive, non-set-aside award reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Andexxa 200 mg vials, with a ceiling value of $17,344.30 and a firm fixed price structure. The delivery order is not set-aside and is scheduled for completion by May 15, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a competitively awarded transaction under the company's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in military and federal healthcare settings. The contract is valued at $6,931.53 with a firm fixed price structure and completion deadline of October 1, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of April 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANDEXXA 200 mg vials. The contract, valued at $19,976.19, is a firm-fixed-price delivery order with an ultimate completion date of August 21, 2024. The award was made on July 31, 2024, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,570.17, is for the supply of ANDEXXA 200 MG VIALS, a specialty pharmaceutical product. This delivery order is issued under an indefinite delivery contract (IDC) with a total potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
- This federal contract award, valued at $14,801.16, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The contract is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen Drug Corporation and DLA, valued at up to $999,999,999.00 and running through December 31, 2025....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,623.64 firm fixed-price contract is for the supply of ANDEXXA 200 MG VIALS, a medical product. There is no set-aside designation for this award. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...